Skip to main content
Journal of Ophthalmic Inflammation and Infection

Table 2 The examination schedule

From: Phase II placebo-controlled study of nepafenac ophthalmic suspension 0.1% for postoperative inflammation and ocular pain associated with cataract surgery in Japanese patients

  1. aBoth eyes
  2. bStudy (operative) eye
Back to article page